RPG Life Sciences issues a revised investor presentation covering unaudited Q3 FY26 results for the quarter ended 31 December 2025, issued under Reg 30 LODR, with Enclosed investor materials for the nine-month period.
AI Assistant
RPG Life Sciences Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.